UPPER LIMB BLOCK USING DEXMEDETOMIDINE.

Alpha2agonist Dexmedetomidine as an adjuvent to local anaesthesia for Supraclavicular block.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2013/04/003598

Enrollment

Registered

2013-04-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients undergoing upper limb surgeries

Interventions

Intervention1: Supraclavicular block using Inj Bupivacaine 0.25% + Dexmedetomedine 30 mcg: Group D : Inj Bupivacaine 0.25% + Dexmedetomedine 30 mcg total Volume 30 ml Control Intervention1: Supraclav

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 and ASA 2 patients posted for upper limb surgeries

Exclusion criteria

Exclusion criteria: ASA 3 and ASA 4 patients Patients with neurological deficit Patients with history of seizures Patients with bleeding disorders Patients with pneumothorax Patient with pregnancy Uncooperative patient Patients refusal

Design outcomes

Primary

Measure	Time frame
Onset of Sensory block Duration of Sensory block Onset of Motor block Duration of Motor block Hemodynamic changes Demand of Analgesia Any other adverse effectsTimepoint: Till the requirements of first analgesia	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr Vaishali Waindeskar

Peoples College of Medical Sciences and Research Center.

vaishaliwaind@gmail.com07554005200

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026